Ironwood Pharmaceuticals | IRWD - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Almirall EUR 114.07M 60.37M 2025-12
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amarin USD 12.54M 28.57M 2025-06
Ardelyx USD -29.77M 35.79M 2026-03
Astellas Pharma JPY 235.24B 136.32B 2026-06
AstraZeneca USD 5.16B 510M 2026-06
Charles River Laboratories USD 272.95M 43.14M 2026-06
Coherus Biosciences USD -43.33M 4.7M 2025-09
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
MacroGenics USD -30.2M 52.15M 2026-03
Moderna USD -1.26B 468M 2026-03
Myriad Genetics USD 14.3M 4M 2025-12
Pacira USD 48.67M 8.43M 2026-06
PTC Therapeutics USD 61.98M 132.97M 2026-03
Puma Biotechnology USD 729K 11.36M 2024-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Takeda JPY 364.46B 214.21B 2026-06
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12